Clinical Trial Update: Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety of the Buprenorphine Transdermal System for acute postoperative pain after total knee replacement; the study was terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• BUPRENORPHINE TRANSDERMAL SYSTEM (buprenorphine)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Postoperative Pain | Phase 2 | Status: TERMINATED | Results posted: 2010-09-21